ELAN (Elanco Animal Health) Interest Expense: $-237 Mil (TTM As of Mar. 2026)

What is Elanco Animal Health Interest Expense?

Elanco Animal Health ELAN +0.81% 66 Interest Expense is $-237 Mil as of Mar. 2026. GuruFocus rates ELAN with a GF Score™ of 66/100 and a GF Value™ of $15.59 (Significantly Overvalued). The stock has 5 warning signs investors should review.

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Elanco Animal Health's interest expense for the three months ended in Mar. 2026 was $ -57 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2026 was $-237 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Elanco Animal Health's Operating Income for the three months ended in Mar. 2026 was $ 169 Mil. Elanco Animal Health's Interest Expense for the three months ended in Mar. 2026 was $ -57 Mil. Elanco Animal Health's Interest Coverage for the quarter that ended in Mar. 2026 was 2.96. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Elanco Animal Health (NYSE:ELAN) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Elanco Animal Health's Interest Expense for the three months ended in Mar. 2026 was $-57 Mil. Its Operating Income for the three months ended in Mar. 2026 was $169 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2026 was $3,918 Mil.

Elanco Animal Health's Interest Coverage for the quarter that ended in Mar. 2026 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Mar. 2026 )	/	Interest Expense (Q: Mar. 2026 )
	=	-1	*	169	/	-57
	=	2.96

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Elanco Animal Health Interest Expense Historical Data

* Premium members only.

The historical data trend for Elanco Animal Health's Interest Expense can be seen below:

Elanco Animal Health Interest Expense Chart

Elanco Animal Health Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Interest Expense

Get a 7-Day Free Trial

-236.00

-241.00

-277.00

-235.00

-220.00

Elanco Animal Health Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
Interest Expense	Get a 7-Day Free Trial															-40.00	-48.00	-52.00	-80.00	-57.00

66GF Score

Elanco Animal Health Inc ELAN

Interest Expense is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Elanco Animal Health Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-237 Mil.

Frequently Asked Questions Learn more about Interest Expense →

What does a Interest Expense of $-237 Mil mean?

Elanco Animal Health (ELAN) has a Interest Expense of $-237 Mil as of Mar. 2026. Interest Expense is the amount a company pays on its long-term debt. View historical data on Elanco Animal Health and its competitors.

Is Elanco Animal Health's Interest Expense too high?

Elanco Animal Health's current Interest Expense is $-237 Mil. Overall, Elanco Animal Health has a GF Score™ of 66/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.

How does Elanco Animal Health's Interest Expense compare to ALKS and HIMS?

Elanco Animal Health's Interest Expense of $-237 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Interest Expense for a Drug Manufacturers company?

A good Interest Expense depends on the Drug Manufacturers industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Interest Expense mean?

A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on Elanco Animal Health and its competitors. Elanco Animal Health's current Interest Expense is $-237 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Elanco Animal Health stock overvalued right now?

Based on GuruFocus' analysis, Elanco Animal Health (ELAN) is currently considered Significantly Overvalued. The stock's GF Value™ is $15.59, compared to a current price of $24.82 — trading 59.2% above its estimated fair value. The current Interest Expense is $-237 Mil. Elanco Animal Health's overall GF Score™ is 66/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Interest Expense calculated?

Interest Expense is calculated from a company's financial statements. For Elanco Animal Health (ELAN), the current Interest Expense is $-237 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Elanco Animal Health (ELAN) Overvalued in 2026?

Based on GuruFocus' analysis, Elanco Animal Health stock appears to be overvalued. The current stock price of $24.82 is trading 59.2% above its estimated GF Value™ of $15.59. GuruFocus considers Elanco Animal Health to be Significantly Overvalued.

Key valuation signals for ELAN:

Interest Expense: $-237 Mil
GF Value™: $15.59 vs. price of $24.82 (59.2% above fair value)
GF Score™: 66/100 with 5 warning signs

No single metric tells the full story. See the ELAN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Elanco Animal Health Business Description

Industry Healthcare Drug Manufacturers

Comparable Companies ALKS HIMS NBIX LNTH LQDA VTRS AMRX INDV KNSA RGC XTER:MRK XSWX:GALD TSE:4502 SHSE:600276 NSE:SUNPHARMA LSE:HLN XTAE:TEVA XSWX:SDZ ZTS UTHR

Other Exchanges 5EA:Germany

Address 450 ELANCO CIRCLE, INDIANAPOLIS, IN, USA, 46221

Website https://www.elanco.com

Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, poultry, and swine production.

66GF Score

Get the complete analysis for ELAN

Interest Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$24.82

Price

$15.59

GF Value

View ELAN Analysis

See Interest Expense data for all stocks →